Highlights Novo Nordisk A/S Nyse

Equities

NVO

US6701002056

Market Closed - Nyse Other stock markets 16:00:02 2024-06-27 EDT			5-day change	1st Jan Change
144.5 ^USD	+0.57%		+2.48%	+39.67%

06-27	European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	MT
06-27	Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	06-27	MT
Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot	06-27	MT
Novo Nordisk to Limit Launch of Wegovy in China, Executive Says	06-27	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	06-26	MT
2seventy Bio Sells Gene Editing Therapy To Novo Nordisk for Up To $40 Million	06-26	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	06-26	MT
Sector Update: Health Care Stocks Lower in Afternoon Trading	06-26	MT
Sector Update: Health Care	06-26	MT
European Equities Close Lower in Wednesday Trading	06-26	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	06-26	MT
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	06-26	MT
Novo Nordisk Halts Late-stage Hypertension, Kidney Disease Treatment Trial; DKK6 Billion Impairment Loss Expected	06-26	MT
Novo Nordisk: trial failure and impact on results	06-26	CF
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	06-26	MT
Novo Nordisk to Take $816 Million Impairment Charge After Stopping Clarion-CKD Trial	06-26	MT
Novo Nordisk makes impairment loss of $816 million in Q2	06-26	RE
China Approves Novo Nordisk's Injection for Long-term Weight Management	06-26	MT
Health Care Up as Novo Nordisk Gets China OK -- Health Care Roundup	06-25	DJ
Sector Update: Health Care Stocks Easing Tuesday Afternoon	06-25	MT
European Equities Close Lower in Tuesday Trading; EC Accuses Microsoft of Breaking Antitrust Laws	06-25	MT